Effect of Local Endometrial Injury on Pregnancy Outcomes During Ovulation Induction Cycles
Launched by AL HAYAT NATIONAL HOSPITAL · Jan 20, 2015
Trial Information
Current as of May 26, 2025
Unknown status
Keywords
ClinConnect Summary
Patients will be randomized using a list of computer generated random sample into two groups:
Group 1: Couples who will undergo endometrial sampling in the luteal phase of the cycle preceding ovulation induction by clomiphene citrate.
Group 2: Couples who will undergo ovulation induction with clomiphene citrate. The drug chosen for ovulation induction in both groups will be clomephine citrate.
Timing and technique of endometrial sampling:
Timing: from day 15 to day 24 of the cycle preceding ovulation induction cycle. Technique: this will be done using the pipelle method (Williams et al....
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Male partner should have a normal semen count and motility according to world health organization criteria (Murray et al., 2012).
- • 2. Primary, secondary or unexplained infertility for at least one year.
- • 3. Failure to conceive with clomiphene citrate in spite of good follicular response for at least 3 cycles.
- • 4. Age varies from 20-35 years with at least one year of infertility.
- • 5. Body mass index between 19-30 kg/m2.
- • 6. Day 2 serum FSH\< 12 IU/ml.
- • 7. Normal uterine cavity on hystrosalpingography.
- • 8. At least one patent tube of normal appearance on HSG.
- • 9. No previous attempts of intrauterine insemination (IUI) or in vitro fertilization (IVF).
- Exclusion Criteria:
- • 1. Infertility due to tubal factor or male factor.
- • 2. Intrauterine organic pathology (myoma, polyp, adhesions) by hystrosalpingogram or diagnostic hysteroscope.
- • 3. Hypogonadotrophic hypogonadism.
About Al Hayat National Hospital
Al Hayat National Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and safety, the hospital provides a state-of-the-art facility equipped with the latest technology and a multidisciplinary team of experienced healthcare professionals. Al Hayat National Hospital focuses on a diverse range of therapeutic areas, fostering collaboration with industry partners and academic institutions to contribute to the advancement of medical knowledge and the development of new therapies. Through its rigorous adherence to ethical standards and regulatory compliance, the hospital aims to enhance the quality of life for patients while driving forward the frontiers of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shebin Elkom, , Egypt
Patients applied
Trial Officials
menoufia university
Study Chair
menoufia fuculty of medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials